HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Suxia Yao Selected Research

Cephalosporins (Cephalosporin Antibiotics)

1/2019Antimicrobial resistance and genetic characterization of Shigella spp. in Shanxi Province, China, during 2006-2016.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Suxia Yao Research Topics

Disease

9Colitis
01/2022 - 12/2011
6Inflammation (Inflammations)
01/2022 - 11/2012
4Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2022 - 12/2011
3Infections
01/2022 - 01/2019
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2022
1Ulcer
01/2021
1Bites and Stings (Sting)
11/2020
1Muscle Cramp (Cramp)
11/2020
1Reinfection
10/2020
1Hypoxia (Hypoxemia)
01/2020
1Diarrhea
01/2019
1Necrosis
11/2015
1Weight Loss (Weight Reduction)
11/2012
1Autosomal Recessive Polycystic Kidney (Polycystic Kidney Disease, Infantile, Type I)
08/2010
1Leber Congenital Amaurosis
02/2010
1Retinal Dystrophies
02/2010
1Megalencephaly
11/2009
1Retinitis Pigmentosa (Pigmentary Retinopathy)
02/2009
1Hypersensitivity (Allergy)
05/2004

Drug/Important Bio-Agent (IBA)

6Interleukin-10 (Interleukin 10)IBA
01/2022 - 01/2018
2Dextrans (Dextran)FDA Link
01/2022 - 10/2018
2sodium sulfate (sodium bisulfate)FDA LinkGeneric
01/2022 - 10/2018
2Dextran SulfateIBA
01/2021 - 11/2012
2Immunoglobulin A (IgA)IBA
10/2020 - 11/2012
2Interleukin-22 (IL-22)IBA
01/2020 - 01/2016
2AntigensIBA
01/2018 - 01/2015
2Interleukin-17 (Interleukin 17)IBA
01/2016 - 11/2014
1InterleukinsIBA
01/2022
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2022
1PropionatesIBA
01/2021
1Hydroxyurea (Hydrea)FDA LinkGeneric
01/2021
1Bromodeoxyuridine (BrdU)IBA
01/2021
110-carboxymethyl-9-acridanoneIBA
11/2020
1vadimezanIBA
11/2020
1Antimicrobial PeptidesIBA
11/2020
1InterferonsIBA
11/2020
1LigandsIBA
11/2020
1DefensinsIBA
11/2020
1Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
01/2020
1FluoroquinolonesIBA
01/2019
1Interleukin-33IBA
01/2019
1Butyrates (Butyrate)IBA
01/2019
1Cephalosporins (Cephalosporin Antibiotics)IBA
01/2019
1CBir1 flagellinIBA
01/2018
1Interleukin-23 (Interleukin 23)IBA
01/2016
1Monoclonal AntibodiesIBA
11/2015
1Infliximab (Remicade)FDA Link
11/2015
1CytokinesIBA
11/2014
1Interleukin-12 (IL 12)IBA
12/2011
1MicroRNAs (MicroRNA)IBA
12/2011
1Phosphotransferases (Kinase)IBA
02/2010
1Proteins (Proteins, Gene)FDA Link
11/2009
1Deoxyribonuclease I (Nickase)IBA
05/2004

Therapy/Procedure

1Oral Administration
01/2022
1Aftercare (After-Treatment)
11/2012
1Ligation
08/2010
1Therapeutics
02/2009